about
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study.Prevalence of bla NDM, bla PER, bla VEB, bla IMP, and bla VIM Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran.Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal.Comparison of Extended-Spectrum β-Lactamase (ESBL) CTX-M Genotypes in Franklin Gulls from Canada and ChileFrequency, Antimicrobial Resistance and Genetic Diversity of Klebsiella pneumoniae in Food Samples.Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.Resistance of Undisturbed Soil Microbiomes to Ceftriaxone Indicates Extended Spectrum β-Lactamase ActivitySusceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection.Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.Characterization of Extended-Spectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria.Prevalence of Extended-spectrum β-Lactamases-producing Escherichia coli from Hospitals in Khartoum State, SudanThe Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against ThemANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.Detection of Ambler class A, B and D ß-lactamases among Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from burn patients.Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli.Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and Tehran hospitals, Iran.Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains.Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.Infection Control Care Bundles Prevents Emergence of Multidrug Resistant Nosocomial Pathogens in Newborn Care Units: A PerspectiveSurvival and Evolution of a Large Multidrug Resistance Plasmid in New Clinical Bacterial Hosts.Phenotypic and Genotypic Methods for Detection of Extended Spectrum β Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolated from Ventilator Associated Pneumonia.Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?Acquisition and dissemination of cephalosporin-resistant E. coli in migratory birds sampled at an Alaska landfill as inferred through genomic analysis.CTX-M-15 is Established in Most Multidrug-Resistant Uropathogenic Enterobacteriaceae and Pseudomonaceae from Hospitals in Nigeria.
P2860
Q24601746-FA82DB94-4B47-493F-B35E-7080C43E6D89Q33668402-F3322035-6DEC-4F1D-B0F3-DF10A1855EBFQ34009785-6C1DE7D2-9DC9-40AA-9532-CD20F25887F9Q34336140-D65A4BA7-D930-4A47-B61C-DFADBDD5A2B2Q35168955-EACB1C0C-E4E2-4500-9D0A-80C73A52488BQ35306037-E06E47AF-08A2-4C9F-95CE-52874D76770AQ35819191-E9B91172-EA4E-416B-BA19-F693A560649BQ35989920-65416E90-510A-479D-9246-9AAAC497E0A0Q36180580-CEEA5C26-126D-4E38-94E3-649B5E50C203Q36265453-82E9675B-C722-4150-92EA-5C6426111769Q36402271-B10696D0-43B9-4E2D-9CE6-B60159D3CC49Q36439179-3BFBCEEF-F829-4FF1-A2A2-4D826DE98BE3Q36566443-7470D453-79A0-4CD1-92F6-452370B3FE1FQ36708459-FB0500B9-75BD-4CEE-B682-39932A2EA711Q36771643-B6495CA4-8042-40C1-9DC9-A48829A7C0B2Q37002208-6782E916-1063-4A68-A728-76175C3FF29AQ37417721-58C15270-3CCC-4706-9A4D-20883E102863Q38253624-4DE0DAE7-D6CE-4F56-A36F-82FF779ED845Q39630910-9FE4533C-AB05-4DC6-A53D-1304B40B0BFEQ40050219-D94761F5-BF5C-41A1-820A-25273EFF6785Q40358195-D0C095FA-38C3-42FA-A99D-2ECCA40FD7ACQ40652529-72145116-9B85-4435-A7C4-6FFB683F113EQ40789108-D7D5819C-DC77-4B64-B481-BB0804722FC2Q40837701-42A4F86B-8967-48A8-99A8-663341214654Q41448496-DC76D999-BFEC-4BA8-B502-3ABF24E3C959Q41987793-CD389027-71CD-4B90-A304-6143404F6126Q47679490-FE2A7643-F886-47AC-A0F0-5895779FB714Q54202941-90E73157-F721-40C2-BE36-C88A46226243Q55154197-B4FC86F4-9BB0-471E-8E4C-AA14DE95A38D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ESBLs: A Clear and Present Danger?
@ast
ESBLs: A Clear and Present Danger?
@en
type
label
ESBLs: A Clear and Present Danger?
@ast
ESBLs: A Clear and Present Danger?
@en
prefLabel
ESBLs: A Clear and Present Danger?
@ast
ESBLs: A Clear and Present Danger?
@en
P2860
P356
P1476
ESBLs: A Clear and Present Danger?
@en
P2093
John Clark
Rishi H-P Dhillon
P2860
P304
P356
10.1155/2012/625170
P577
2011-06-06T00:00:00Z